financetom
Business
financetom
/
Business
/
Blue Owl Technology Finance to Begin Trading on NYSE Thursday
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Blue Owl Technology Finance to Begin Trading on NYSE Thursday
Jun 11, 2025 9:28 AM

12:12 PM EDT, 06/11/2025 (MT Newswires) -- Blue Owl Technology Finance said Wednesday it has received approval to list on the New York Stock Exchange.

The company said its stock will begin trading on the NYSE on June 12 under the ticker symbol OTF.

Price: 19.30, Change: +0.23, Percent Change: +1.18

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Schwab Charles Insider Sold Shares Worth $980,635, According to a Recent SEC Filing
Schwab Charles Insider Sold Shares Worth $980,635, According to a Recent SEC Filing
May 26, 2025
04:25 PM EDT, 05/05/2025 (MT Newswires) -- Paul V Woolway, Managing Director, Chief Banking Officer, on May 01, 2025, sold 11,994 shares in Schwab Charles (SCHW) for $980,635. Following the Form 4 filing with the SEC, Woolway has control over a total of 52,185 common shares of the company, with 52,185 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/316709/000203131325000013/xslF345X05/wk-form4_1746475274.xml ...
TIMELINE-From non-profit roots to for-profit ambitions: the OpenAI saga
TIMELINE-From non-profit roots to for-profit ambitions: the OpenAI saga
May 26, 2025
(Updates to add latest events related to OpenAI) May 5 (Reuters) - ChatGPT creator OpenAI said it would remain under the control of its nonprofit parent, following a storm of criticism and legal challenges, including a high-profile lawsuit filed by rival and co-founder Elon Musk. OpenAI is still pushing ahead with plans to change the structure of its for-profit arm...
Neurocrine Biosciences Q1 Non-GAAP Earnings Fall, Sales Rise; Maintains 2025 Guidance
Neurocrine Biosciences Q1 Non-GAAP Earnings Fall, Sales Rise; Maintains 2025 Guidance
May 26, 2025
04:23 PM EDT, 05/05/2025 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) reported Q1 non-GAAP earnings late Monday of $0.70 per diluted share, down from $1.20 a year earlier. Analysts polled by FactSet expected $1.18. Sales for the quarter ended March 31 were $572.6 million, up from $515.3 million a year earlier. Analysts surveyed by FactSet expected $559.6 million. The...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved